Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human EEA1 Protein, N-His-SUMO & C-Strep

Recombinant Human EEA1 Protein, N-His-SUMO & C-Strep from ProteoGenix; catalogue ARO-P11219; research use only.

SKU:
ABM141657-1
Manufacturer SKU
ARO-P11219
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant proteins are proteins that are produced through genetic engineering techniques, where the gene for a specific protein is inserted into a host organism, such as bacteria or yeast, to produce large quantities of the protein. These proteins have a wide range of applications in various fields, including medicine, biotechnology, and research. One such protein is the Recombinant Human EEA1 Protein, which has gained significant attention due to its unique structure, activity, and potential applications.

Structure of Recombinant Human EEA1 Protein

The Recombinant Human EEA1 Protein is a 162 kDa protein that belongs to the Early Endosome Antigen 1 (EEA1) family. It is a cytosolic protein that is involved in the regulation of endosome dynamics and membrane trafficking. The protein is composed of 1366 amino acids and contains several functional domains, including a Rab5-binding domain, a FYVE domain, and a coiled-coil domain. These domains play a crucial role in the protein’s activity and function.

Activity of Recombinant Human EEA1 Protein

The primary function of Recombinant Human EEA1 Protein is to regulate endosome dynamics and membrane trafficking. It is a key component of the endosome fusion machinery and is responsible for the fusion of early endosomes with late endosomes. This process is essential for the sorting and delivery of cargo molecules to their respective destinations within the cell. The Rab5-binding domain of the protein allows it to interact with the small GTPase protein Rab5, which is involved in the formation and maturation of early endosomes.

In addition to its role in endosome dynamics, Recombinant Human EEA1 Protein also plays a crucial role in autophagy, a cellular process that involves the degradation of damaged or unnecessary cellular components. The protein interacts with several autophagy-related proteins, including LC3 and ATG12, to regulate the formation and maturation of autophagosomes.

Applications of Recombinant Human EEA1 Protein

Due to its unique structure and activity, Recombinant Human EEA1 Protein has a wide range of potential applications. One of the most significant applications is in the study of endosome dynamics and membrane trafficking. The protein can be used in in vitro and in vivo experiments to understand the mechanisms involved in these processes and their regulation. It can also be used to study the role of early endosomes in various cellular processes, such as cell signaling and nutrient uptake.

Recombinant Human EEA1 Protein also has potential applications in drug discovery and development. As it is involved in the regulation of autophagy, the protein can be targeted for the development of novel therapeutics for diseases that involve dysregulation of this process, such as cancer and neurodegenerative disorders.

Furthermore, the protein has diagnostic applications as well. Its interaction with Rab5 and other proteins can be used as a biomarker for certain diseases, providing a potential diagnostic tool for early detection and treatment.

Conclusion

In summary, Recombinant Human EEA1 Protein is a unique and versatile protein with a crucial role in endosome dynamics, autophagy, and other cellular processes. Its structure and activity make it a valuable tool for studying these processes and their regulation, as well as for potential applications in drug discovery and diagnostics. With ongoing research and advancements in genetic engineering techniques, the potential for this protein in various fields is vast, and it will continue to be a subject of interest and investigation in the scientific community.

ProteoGenix catalogue number ARO-P11219. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 23.27 kDa; Fragment: Ala1325-Gly1411; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
EEA1, Endosome-associated protein p162, Zinc finger FYVE domain-containing protein 2, ZFYVE2, Early endosome antigen 1
Host species
E. coli
Source organism
Human
Molecular weight
23.27 kDa
Sequence fragment
Ala1325-Gly1411
Sequence
AAVQELGRENQSLQIKHTQALNRKWAEDNEVQNCMACGKGFSVTVRRHHCRQCGNIFCAECSAKNALTPSSKKPVRVCDACFNDLQG
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11219
UniProt accession
Q15075
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
$215.00$172.00